These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8186484)

  • 1. Deep vein thrombosis in end-stage renal disease.
    Ifudu O; Delaney VB; Barth RH; Friedman EA
    ASAIO J; 1994; 40(1):103-5. PubMed ID: 8186484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet dysfunction and end-stage renal disease.
    Kaw D; Malhotra D
    Semin Dial; 2006; 19(4):317-22. PubMed ID: 16893410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased coated-platelet levels in chronic haemodialysis patients.
    Valaydon ZS; Lee P; Dale GL; Januszewski AS; Rowley KG; Nandurkar H; Karschimkus C; Best JD; Lyons TJ; Jenkins AJ
    Nephrology (Carlton); 2009 Apr; 14(2):148-54. PubMed ID: 19076292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis.
    Rios DR; Carvalho Md; Lwaleed BA; Simões e Silva AC; Borges KB; Dusse LM
    Clin Chim Acta; 2010 Feb; 411(3-4):135-9. PubMed ID: 19945449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter.
    Yu A; Egberg N; Jacobson SH
    Scand J Clin Lab Invest; 2003; 63(2):127-33. PubMed ID: 12751694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet adhesion testing may predict early hemodialysis arteriovenous graft and fistula failure in end-stage renal disease patients.
    ElChoufani SE; Bolin P; Waien S; Christiano CR; Holbert D; Bode AP
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):399-409. PubMed ID: 18160614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and late outcome of cardiac surgery in dialysis-dependent patients: single-center experience with 245 consecutive patients.
    Rahmanian PB; Adams DH; Castillo JG; Vassalotti J; Filsoufi F
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):915-22. PubMed ID: 18374780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease profile, complications and outcome in patients on maintenance haemodialysis at King Faisal University Hospital, Saudi Arabia.
    al-Muhanna FA; Saeed I; al-Muelo S; Larbi E; Rubaish A
    East Afr Med J; 1999 Dec; 76(12):664-7. PubMed ID: 10734534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arteriovenous thrombosis in chronic renal failure patients receiving renal replacement therapy.
    Shoaib M; Shamsi TS; Naz A
    J Coll Physicians Surg Pak; 2008 Jul; 18(7):418-23. PubMed ID: 18760065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascites in a patient undergoing maintenance hemodialysis.
    Kes P; Ratković-Gusić I; Sefer S
    Acta Med Croatica; 1997; 51(1):57-61. PubMed ID: 9115105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet dysfunction in renal failure.
    Boccardo P; Remuzzi G; Galbusera M
    Semin Thromb Hemost; 2004 Oct; 30(5):579-89. PubMed ID: 15497100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spontaneous renal bleeding in haemodialysis patients].
    Groeneveld JH; van Buren M; van Overhagen H
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1789-93. PubMed ID: 18754314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis.
    Cano AE; Neil AK; Kang JY; Barnabas A; Eastwood JB; Nelson SR; Hartley I; Maxwell D
    Am J Gastroenterol; 2007 Sep; 102(9):1990-7. PubMed ID: 17511755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of pre-existing end-stage renal disease on survival in acutely injured trauma patients.
    Lorelli DR; Kralovich KA; Seguin C
    Am Surg; 2001 Jul; 67(7):693-6. PubMed ID: 11450792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma in native kidneys of patients with end stage renal disease.
    Shingleton WB; Blalock J; Clark J; Bigler SA
    J Miss State Med Assoc; 1998 Mar; 39(3):86-9. PubMed ID: 9538592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.
    Hocher B; Liefeldt L; Quaschning T; Kalk P; Ziebig R; Godes M; Relle K; Asmus G; Stasch JP
    J Am Soc Nephrol; 2007 Apr; 18(4):1323-30. PubMed ID: 17314326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.